Tag:#Grow Group

From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a...

‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’

The Advisory Council for the Misuse of Drugs' recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow...

‘Repeat & Scale’: Grow Group Set For Expansion Into Germany, Europe And Beyond

UK innovator Grow Group is raising £6m to fund its expansion into Europe - with aims to be the global powerhouse of cannabis medicines...

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read